Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (321-330 of 333) with videos related to

Pageof 34
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 25, 2019
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastomaA F Cardona, L Rojas, B Wills, et al.
Thoracic Cancer|February 2, 2019
Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP)Leonardo Rojas, Andrés F Cardona, Rogelio Trejo-Rosales, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 6, 2023
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing CountryClaudia Cifuentes, Milton Lombana, Henry Vargas, et al.
Neuro-Oncology|July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trialAndrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
Targeted Oncology|April 5, 2023
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort StudyDiego F Chamorro, Andrés F Cardona, July Rodríguez, et al.
Clinical Lung Cancer|July 7, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)Andrés F Cardona, Alejandro Ruiz-Patiño, Gonzalo Recondo, et al.
Critical Reviews in Oncology/Hematology|July 11, 2020
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative groupOscar Arrieta, Andrés F Cardona, Luis Lara-Mejía, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2022
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)Vladmir C Cordeiro de Lima, Marcelo Corassa, Erick Saldanha, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2024
Educational disparities in brain health and dementia across Latin America and the United StatesRaul Gonzalez-Gomez, Agustina Legaz, Sebastián Moguilner, et al.
Nature Aging|December 28, 2024
Structural inequality linked to brain volume and network dynamics in aging and dementia across the AmericasAgustina Legaz, Florencia Altschuler, Raul Gonzalez-Gomez, et al.
Pageof 34

Showing results (321-330 of 333) with videos related to

Sort By:
Pageof 34
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 25, 2019
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastomaA F Cardona, L Rojas, B Wills, et al.
Thoracic Cancer|February 2, 2019
Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP)Leonardo Rojas, Andrés F Cardona, Rogelio Trejo-Rosales, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 6, 2023
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing CountryClaudia Cifuentes, Milton Lombana, Henry Vargas, et al.
Neuro-Oncology|July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trialAndrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
Targeted Oncology|April 5, 2023
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort StudyDiego F Chamorro, Andrés F Cardona, July Rodríguez, et al.
Clinical Lung Cancer|July 7, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)Andrés F Cardona, Alejandro Ruiz-Patiño, Gonzalo Recondo, et al.
Critical Reviews in Oncology/Hematology|July 11, 2020
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative groupOscar Arrieta, Andrés F Cardona, Luis Lara-Mejía, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2022
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)Vladmir C Cordeiro de Lima, Marcelo Corassa, Erick Saldanha, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2024
Educational disparities in brain health and dementia across Latin America and the United StatesRaul Gonzalez-Gomez, Agustina Legaz, Sebastián Moguilner, et al.
Nature Aging|December 28, 2024
Structural inequality linked to brain volume and network dynamics in aging and dementia across the AmericasAgustina Legaz, Florencia Altschuler, Raul Gonzalez-Gomez, et al.
Pageof 34